Potato Cell Or Cell Line, Per Se Patents (Class 435/417)
  • Patent number: 11678668
    Abstract: The present disclosure provides non-intergeneric remodeled microbes that are able to fix atmospheric nitrogen and deliver such to plants in a targeted, efficient, and environmentally sustainable manner. The utilization of the taught microbial products will enable farmers to realize more productive and predictable crop yields without the nutrient degradation, leaching, or toxic runoff associated with traditional synthetically derived nitrogen fertilizer. The remodeled microbes taught herein are able to be combined with leading agricultural chemistry and elite germplasm. Furthermore, the disclosure provides seed treatments comprising remodeled microbes.
    Type: Grant
    Filed: January 14, 2022
    Date of Patent: June 20, 2023
    Assignee: PIVOT BIO, INC.
    Inventors: Mark Reisinger, Ernest Sanders, Richard Broglie, Karsten Temme
  • Patent number: 11597770
    Abstract: The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to E-selectin. The invention includes uses, and associated methods of using the antibodies, and antigen-binding fragments thereof.
    Type: Grant
    Filed: January 21, 2021
    Date of Patent: March 7, 2023
    Assignee: Pfizer Inc.
    Inventors: James Reasoner Apgar, Sheryl Rubio Bowley, Joanne Elizabeth-Ayriss Elwell, Laura Lin, Jatin Narula, Chuenlei Parng, Debra Denene Pittman, Swapnil Rakhe, Chihyi Vincent Yu
  • Patent number: 11542516
    Abstract: Recombinant DNA molecules and constructs including sequences derived from Tripsacum dactyloides are provided, which are useful for modulating gene expression in plants. Transgenic plants, plant cells, plant parts, and seeds are also provided, comprising a recombinant DNA molecule operably linked to a heterologous transcribable DNA molecule, as well as methods of their use.
    Type: Grant
    Filed: August 14, 2019
    Date of Patent: January 3, 2023
    Assignee: MONSANTO TECHNOLOGY, LLC
    Inventors: Stanislaw Flasinski, Jun Zhang, Suling Zhao
  • Patent number: 10143176
    Abstract: A new and distinct clonal line plant of Solanum tuberosum L. named KI964 and characterized by elevated levels of proteinase inhibitor II.
    Type: Grant
    Filed: December 8, 2016
    Date of Patent: December 4, 2018
    Assignee: KEMIN INDUSTRIES, INC.
    Inventors: Brindha Narasimhamoorthy, Liuqing Zhao, Xin Liu, John A. Greaves
  • Patent number: 10130066
    Abstract: A new and distinct clonal line plant of Solanum tuberosum L. named KI969 and characterized by elevated levels of proteinase inhibitor II.
    Type: Grant
    Filed: December 8, 2016
    Date of Patent: November 20, 2018
    Assignee: KEMIN INDUSTRIES, INC.
    Inventors: Brindha Narasimhamoorthy, Liuqing Zhao, Xin Liu, John A. Greaves
  • Patent number: 9523097
    Abstract: The present invention relates to transplastomic guayule plants comprising chloroplasts engineered to express the complete cytosolic mevalonic acid (MEV) pathway.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: December 20, 2016
    Assignee: The United States of America, as represented by the Secretary of Agriculture
    Inventors: Byung-Guk Kang, Colleen M McMahan, Maureen C Whalen, Niu Dong, Shashi Kumar
  • Publication number: 20150096070
    Abstract: The present invention provides novel promoters for use in plants. Specifically, the present invention provides novel chimeric promoters comprising combinations of plant viral enhancer elements and plant promoters. The present invention also provides DNA constructs; transgenic cells, plants, and seeds containing these novel chimeric promoters; and methods for preparing and using the same.
    Type: Application
    Filed: November 25, 2014
    Publication date: April 2, 2015
    Inventor: STANISLAW FLASINSKI
  • Publication number: 20150096083
    Abstract: The present invention provides non-coding regulatory element polynucleotide molecules isolated from the lipid transfer protein (LTP) gene of Oryza sativa and useful for expressing transgenes in plants. The invention further discloses compositions, polynucleotide constructs, transformed host cells, transgenic plants and seeds containing the Oryza sativa regulatory polynucleotide sequences, and methods for preparing and using the same.
    Type: Application
    Filed: July 28, 2014
    Publication date: April 2, 2015
    Inventors: Wei Wu, Qi Wang, James Morrell, Linda Lutfiyya, Maolong Lu, Zhaolong Li, Ping Li, Michelle Lacy, David Kovalic, Yongwei Cao, Andrey Boukharov, Stanislaw Flasinski, Peter T. Hajdukiewicz
  • Publication number: 20150082485
    Abstract: The present invention is drawn to novel genes from wild plants, such as wild potato and pepper plants, that confer potyvirus resistance to plants, such as in transformed cultivated plants. Also encompassed are cultivated plants transformed with the novel gene, food products made from the transformed cultivated plants, and methods for making such plants and food products.
    Type: Application
    Filed: November 25, 2014
    Publication date: March 19, 2015
    Inventors: Caius Rommens, Hui Duan, Rekha Chawla
  • Publication number: 20150082495
    Abstract: The present invention relates to control of plant pathogens, particularly fungi or oomycetes, by inhibiting one or more biological functions, particularly by inhibiting saccharopine dehydrogenase gene(s) using RNA interference. The invention provides methods and compositions using RNA interference of plant pathogens target genes for such control. The invention is also directed to methods for making transgenic plants tolerant to said plant pathogens, and to transgenic plants and seeds generated thereof.
    Type: Application
    Filed: October 3, 2012
    Publication date: March 19, 2015
    Applicant: Bayer Intellectual Property GmbH
    Inventors: Thomas Delebarre, Cécile Dorme, Bernd Essigmann, Frédéric Schmitt, François Villalba, Eric Paget
  • Publication number: 20150067923
    Abstract: Plant genes regulated by transcription factors that control the gene network response to an environmental perturbation or signal are described. This class of genes responds to the perturbation of a transcription factor and the signal it transduces, but surprisingly, without stable binding of the transcription factor. These genes represent members of the “dark matter” of metabolic regulatory circuits. The invention involves the transgenic manipulation of these “response genes” and/or the genes encoding their regulatory transcription factors in plants so that their respective gene products are either overexpressed or underexpressed in the plant in order to confer a desired phenotype. The invention also relates to a rapid technique named “TARGET” (Transient Assay Reporting Genome-wide Effects of Transcription factors) for determining such “response genes” and their transcription factors by perturbation of the expression of the transcription factors of interest in protoplasts of any plant species.
    Type: Application
    Filed: August 12, 2014
    Publication date: March 5, 2015
    Applicant: New York University
    Inventors: Gloria Coruzzi, Kenneth Birnbaum, Bastiaan Bargmann, Gabriel Krouk
  • Publication number: 20150047076
    Abstract: The present invention provides novel insecticidal proteins active against a Coleopteran and/or Hemipteran species pest, which include, but are not limited to, TIC3131, TIC3400 and TIC3407 proteins. The present invention also provides a DNA construct comprising operably linked to a heterologous promoter a polynucleotide that encodes the novel insecticidal protein or an insecticidal fragment thereof. The present invention further provides transgenic plants/plant cells/plant parts expressing the insecticidal proteins, methods for detecting the presence of the polynucleotide or the protein in a biological sample, and methods of controlling a Coleopteran and/or Hemipteran species pest using the insecticidal proteins.
    Type: Application
    Filed: August 8, 2014
    Publication date: February 12, 2015
    Applicant: Monsanto Technology LLC
    Inventors: Heather M. Anderson, David J. Bowen, Catherine A. Chay, Stanislaw Flasinski, Uma R. Kesanapalli, Jason S. Milligan, Rachael N. Slightom, Yong Yin
  • Publication number: 20150023967
    Abstract: The present invention relates to a binding molecule which is at least bispecific comprising a first and a second binding domain, wherein the first binding domain is capable of binding to epitope cluster3 of BCMA, and the second binding domain is capable of binding to the Tcell CD3 receptor complex. Moreover, the invention provides a nucleic acid sequence encoding the binding molecule, a vector comprising said nucleic acid sequence and a host cell transformed or transfected with said vector. Furthermore, the invention provides a process for the production of the binding molecule of the invention, a medical use of said binding molecule and a kit comprising said binding molecule.
    Type: Application
    Filed: November 15, 2012
    Publication date: January 22, 2015
    Inventors: Peter Kufer, Tobias Raum, Patrick Hoffmann, Roman Kischel, Ralf Lutterbuese, Doris Rau, Paul Adam, Eric Borges, Barbara Hebeis, Susanne Hipp
  • Publication number: 20150024009
    Abstract: The invention provides an isolated genetically modified non-mammalian organism, wherein the activity of acyl-CoA:sterol acyltransferase/sterol O-acyltransferase (EC 2.3.1.26) and/or diacylglycerol acyltransferase/diacylglycerol O-acyltranferase (EC 2.3.1.20) and/or lecithin cholesterol acyl transferase/phospholipid: diacylglycerol acyltransferase (EC 2.3.1.158) and/or acyl CoA-wax alcohol acyltransferase (EC 2.3.1.75) is reduced or abolished in comparison with a corresponding wildtype organism, methods of use of such an organism, shuttle vehicles for making such an organism and methods for producing such an organism.
    Type: Application
    Filed: September 19, 2014
    Publication date: January 22, 2015
    Applicant: ORGANOBALANCE GMBH
    Inventors: Christine Lang, Andreas Raab
  • Publication number: 20150020241
    Abstract: The present invention provides non-coding regulatory element polynucleotide molecules isolated from the S-adenosyl methionine synthetase (SAMS3) gene of Arabidopsis thaliana and useful for expressing transgenes in plants. The invention further discloses compositions, polynucleotide constructs, transformed host cells, transgenic plants and seeds containing the Arabidopsis thaliana regulatory polynucleotide sequences, and methods for preparing and using the same.
    Type: Application
    Filed: June 6, 2014
    Publication date: January 15, 2015
    Inventors: Wei Wu, Qi Wang, Michael Edgerton, Kim Beazley, Jill Deikman, Michael W. Petersen, Bei Zhang
  • Publication number: 20150020242
    Abstract: A novel promoter useful for altering the color of flowers of a plant, which is selected from the group consisting of: (1) a nucleic acid which comprises the nucleotide sequence represented by SEQ ID NO: 20, SEQ ID NO: 12 or SEQ ID NO: 21; and (2) a nucleic acid which maintains the same promoter activity as that of the nucleotide sequence represented by SEQ ID NO: 20, SEQ ID NO: 12 or SEQ ID NO: 21, and which comprises a nucleotide sequence that is produced by modifying the original nucleotide sequence by the addition, deletion and/or substitution of one or several nucleotide sequences, or can hybridize with a nucleotide acid comprising a nucleotide sequence complementary to the original nucleotide sequence under highly stringent conditions, or has a 90% or more sequence identity to the original nucleotide sequence.
    Type: Application
    Filed: February 19, 2013
    Publication date: January 15, 2015
    Applicant: SUNTORY HOLDINGS LIMITED
    Inventors: Yoshikazu Tanaka, Yukihisa Katsumoto
  • Publication number: 20150013031
    Abstract: The present invention relates to methods and compositions for improving the efficiency of Agrobacterium- and Rhizobium-mediated plant cell transformation by use of additional transformation enhancer sequences, such as overdrive or TSS sequences, operably linked to a T-DNA border sequence on a recombinant construct that comprises T-DNA.
    Type: Application
    Filed: June 3, 2014
    Publication date: January 8, 2015
    Inventors: Larry A. Gilbertson, Xudong Ye
  • Publication number: 20150007363
    Abstract: The subject invention pertains to novel mutant polynucleotide molecules that encode enzymes that have increased heat stability. These polynucleotides, when expressed in plants, result in increased yield in plants grown under conditions of heat stress. The polynucleotide molecules of the subject invention encode maize endosperm ADP glucose pyrophosphorylase (AGP) and soluble starch synthase (SSS) enzyme activities. Plants and plant tissue bred to contain, or transformed with, the mutant polynucleotides, and expressing the polypeptides encoded by the polynucleotides, are also contemplated by the present invention. The subject invention also concerns methods for isolating polynucleotides and polypeptides contemplated within the scope of the invention. Methods for increasing yield in plants grown under conditions of heat stress are also provided.
    Type: Application
    Filed: July 1, 2014
    Publication date: January 1, 2015
    Inventors: L. CURTIS HANNAH, THOMAS W. GREENE
  • Publication number: 20140380525
    Abstract: A transgenic plant comprising a polynucleotide encoding a nitrogen utilization protein operably linked to a PBpr1 promoter is provided. The transgenic plant exhibits increased nitrogen use efficiency, increased biomass and/or increased seed yield. Seeds from such transgenic plants, genetic constructs to prepare such plants, methods of generating and growing transgenic plants are also provided.
    Type: Application
    Filed: September 7, 2012
    Publication date: December 25, 2014
    Applicant: BAYER CROPSCIENCE AG
    Inventors: Allen Good, Yee Ying Lock, Perrin H. Beatty
  • Publication number: 20140342404
    Abstract: The present invention concerns polypeptides comprising a variant Fc region. More particularly, the present invention concerns Fc region-containing polypeptides that have altered effector function as a consequence of one or more amino acid modifications in the Fc region thereof.
    Type: Application
    Filed: April 10, 2013
    Publication date: November 20, 2014
    Applicant: GENENTECH, INC.
    Inventor: Leonard G. PRESTA
  • Publication number: 20140342450
    Abstract: Provided are antibodies including human antibodies and antigen-binding portions thereof that specifically bind to CCR2, preferably human CCR2, and that may inhibit CCR2. The present antibodies may bind to the first and/or second extracellular loops of CCR2. Isolated heavy and light chains derived from the antibodies and nucleic acid molecules encoding the antibodies and chains are provided. Methods of making and using the anti-CCR2 antibodies or antigen-binding portions, and compositions comprising these antibodies or antigen-binding portions, including compositions for diagnosis and treatment, are provided. Also provided are gene therapy methods using nucleic acid molecules encoding the heavy and/or light chains that comprise the human anti-CCR2 antibodies or antigen-binding portions thereof.
    Type: Application
    Filed: April 3, 2014
    Publication date: November 20, 2014
    Applicants: Amgen Fremont Inc., Pfizer Inc.
    Inventors: Ronald P. Gladue, Bradley T. Keller, Shinji Ogawa, Arvind Rajpal, Laurie A. Tylaska, Shelley Sims Belouski, Larry L. Green, Meina L. Liang
  • Publication number: 20140328995
    Abstract: A potato cultivar designated J55 is disclosed. The invention relates to tubers of potato cultivar J55, to seeds of potato cultivar J55, to plants and plant parts of potato cultivar J55, to food products produced from potato cultivar J55, and to methods for producing a potato plant by crossing potato cultivar J55 with itself or with another potato variety. The invention also relates to methods for producing a transgenic potato plant and to the transgenic potato plants and parts produced by those methods. This invention also relates to potato plants and plant parts derived from potato cultivar J55, to methods for producing other potato plants or plant parts derived from potato cultivar J55 and to the potato plants and their parts derived from use of those methods. The invention further relates to hybrid potato tubers, seeds, plants and plant parts produced by crossing potato cultivar J55 with another potato cultivar.
    Type: Application
    Filed: April 29, 2014
    Publication date: November 6, 2014
    Applicant: J.R. SIMPLOT COMPANY
    Inventors: Pete Clark, Susan Fortier Collinge
  • Publication number: 20140328994
    Abstract: A potato cultivar designated E12 is disclosed. The invention relates to the tubers of potato cultivar E12, to the seeds of potato cultivar E12, to the plants of potato E12, to the plant parts of potato cultivar E12, to food products produced from potato cultivar E12, and to methods for producing a potato plant produced by crossing potato cultivar E12 with itself or with another potato variety. The invention also relates to methods for producing a potato plant containing in its genetic material one or more transgenes and to the transgenic potato plants and plant parts produced by those methods. This invention also relates to potato cultivars or breeding cultivars and plant parts derived from potato variety E12, to methods for producing other potato cultivars, lines or plant parts derived from potato cultivar E12 and to the potato plants, varieties, and their parts derived from use of those methods.
    Type: Application
    Filed: November 5, 2013
    Publication date: November 6, 2014
    Applicant: J.R. SIMPLOT COMPANY
    Inventors: Pete CLARK, Susan Fortier COLLINGE
  • Publication number: 20140322218
    Abstract: The present invention provides to a antibody construct comprising a first human binding domain capable of binding to human CDH19 on the surface of a target cell and a second domain capable of binding to human CD3 on the surface of a T cell. Moreover, the invention relates to a nucleic acid sequence encoding the antibody construct, a vector comprising said nucleic acid sequence and a host cell transformed or transfected with said vector. Furthermore, the invention relates a process for the production of the antibody construct of the invention, a medical use of said antibody construct and a kit comprising said antibody construct.
    Type: Application
    Filed: January 27, 2014
    Publication date: October 30, 2014
    Applicant: AMGEN RESEARCH (MUNICH) GMBH
    Inventors: Shouhua Xiao, Zheng Pan, Dineli Wickramasinghe, Shawn Jeffries, Chadwick T. King, Brian Mingtung Chan, Peter Kufer, Ralf Lutterbüse, Tobias Raum, Patrick Hoffmann, Doris Rau, Roman Kischel, Bryan Lemon, Holger Wesche
  • Publication number: 20140322221
    Abstract: The present application describes engineered antibodies, with three or more functional antigen binding sites, and uses, such as therapeutic applications, for such engineered antibodies.
    Type: Application
    Filed: March 28, 2014
    Publication date: October 30, 2014
    Applicant: Genentech, Inc.
    Inventors: Kathy L. MILLER, Leonard G. PRESTA
  • Publication number: 20140322812
    Abstract: This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system and methods of modulating the expression of a gene in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic organisms.
    Type: Application
    Filed: April 24, 2014
    Publication date: October 30, 2014
    Applicant: Intrexon Corporation
    Inventors: Subba Reddy PALLI, Mohan Basavaraju KUMAR
  • Publication number: 20140308271
    Abstract: The present invention relates to antibodies or fragments thereof that bind to TL1A. More specifically, the present invention relates to an antibody or fragment thereof that binds to TL1A comprising a heavy chain CDR1 comprising the amino acid sequence of SEQ ID NO: 51, and/or a heavy chain CDR2 comprising the amino acid sequence of SEQ ID NO: 52, and/or a heavy chain CDR3 comprising the amino acid sequence of SEQ ID NO: 53; and/or comprising a light chain CDR1 comprising the amino acid sequence of SEQ ID NO: 54, and/or a light chain CDR2 comprising the amino acid sequence of SEQ ID NO: 55 and/or a light chain CDR3 comprising the amino acid sequence of SEQ ID NO: 56.
    Type: Application
    Filed: January 2, 2014
    Publication date: October 16, 2014
    Applicant: GLENMARK PHARMACEUTICALS S.A.
    Inventors: ANTOINE ATTINGER, JONATHAN ALBERT BACK, STANISLAS BLEIN, RAMI LISSILAA, DARKO SKEGRO
  • Publication number: 20140304853
    Abstract: Disclosed herein are methods and compositions for parallel or sequential transgene stacking in plants to produce plants with selected phenotypes.
    Type: Application
    Filed: April 2, 2014
    Publication date: October 9, 2014
    Inventors: W. Michael Ainley, Dmitry Y. Guschin, Matthew Hayden, Daniel Isenegger, John Mason, Jeffrey C. Miller, Joseph F. Petolino, Yidong Ran, Tim Sawbridge, German Spangenberg, Steven R. Webb
  • Publication number: 20140298543
    Abstract: The invention provides compositions and methods for manipulating the exchange of water and/or carbon dioxide (CO2) through plant stomata by controlling CO2 sensor genes. The invention provides compositions and methods for enhancing or optimizing biomass accumulation in a plant. The invention provides compositions and methods for opening or closing a stomatal pore on a guard cell in the epidermis of a plant. The invention provides compositions and methods for increasing or decreasing oxygenation efficiency and/or carbon fixation in a guard cell in the epidermis of a plant by manipulating expression of a ribulose-1,5-bisphosphate carboxylase/oxygenase. The invention provides promoters for regulating expression of a nucleic acid in a plant guard cell.
    Type: Application
    Filed: March 5, 2014
    Publication date: October 2, 2014
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Julian I. SCHROEDER, Maria ISRAELSSON-NORDSTROM, Josef M. KUHN, Yingzhen YANG, Honghong HU, Aurelien BOISSON-DERNIER
  • Publication number: 20140256930
    Abstract: An object of the present invention is to provide a method for converting the coenzyme dependency of enzymes of the medium-chain dehydrogenase/reductase (MDR) family. A further object of the present invention is to provide enzyme variants of the MDR family whose coenzyme dependency is converted by the conversion method and a method for enzymatically producing optically active alcohols using the enzymes. The present inventors developed a novel enzyme conversion method for converting the coenzyme dependency of enzymes of the MDR family, rationally designed enzyme variants that are altered by the enzyme conversion method to be able to use NADPH as a coenzyme from a useful enzyme of the MDR family that uses NADH as a coenzyme, and actually provide variants having such an ability.
    Type: Application
    Filed: June 27, 2012
    Publication date: September 11, 2014
    Applicant: KANEKA CORPORATION
    Inventors: Shinichi Yoshida, Shunichi Taira, Masakatsu Nishihachijyo, Masutoshi Nojiri, Shigeru Kawano
  • Publication number: 20140259220
    Abstract: The present invention provides methods for increasing plant biomass and plant seed yield through overexpression of a PHB gene. Also provided are plants with increased biomass and seed yield comprising overexpression of a PHB gene produced by such methods. Plants described herein may be used, for example, for improved production of biofuels.
    Type: Application
    Filed: March 5, 2014
    Publication date: September 11, 2014
    Applicant: The Texas A&M University System
    Inventor: Shuhua Yuan
  • Publication number: 20140237689
    Abstract: The present invention provides metabolic regulators, which are proteins (such as fusion proteins, truncated proteins or full-length proteins) that bind to specific metabolites and which can be used to control the availability of the metabolites in cells, particularly plant cells. Proteins of the invention include one or more metabolic regulator proteins, can be truncated or full length, can further comprise a transmembrane domain or lipoylation site or can further comprise a transit peptide. Metabolic regulators of the invention can be soluble, e.g., cytosolic soluble, can be anchored to a biological membrane or can be organelle targeted or apoplastic targeted. The present invention also provides nucleic acid molecules encoding the metabolic regulators, methods of making the nucleic acid molecules, methods for making transformed organisms, including plants, photosynthetic organisms, microbes, invertebrates, and vertebrates, and methods for controlling availability of metabolites to a host cell.
    Type: Application
    Filed: May 2, 2014
    Publication date: August 21, 2014
    Applicant: PLANT SENSORY SYSTEMS, LLC
    Inventors: Frank J. Turano, Kathleen A. Turano
  • Patent number: 8802931
    Abstract: The present invention provides transgenic plants transformed with exogenous nucleic acid encoding a Dunaliella plasma membrane (PM)-ATPase. The transgenic plant has increased tolerance to salt as compared to a corresponding non-transgenic plant. The present invention also provides nucleic acids encoding a chimeric PM-ATPase, which comprise a first portion encoding a plant PM-ATPase or a fragment thereof, and a second portion encoding a Dunaliella PM-ATPase or a fragment thereof. The present invention also discloses a method of producing a transgenic plant having an increased tolerance to salt as compared to a corresponding non-transgenic plant, a method of modifying a plant capacity to survive salt shock, and a method of modifying plant recovery after exposure to salt stress, by introducing into one or more cells of a plant an exogenous nucleic acid encoding a Dunaliella PM-ATPase.
    Type: Grant
    Filed: September 1, 2005
    Date of Patent: August 12, 2014
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Uri Pick, Orna Livneh, Eli Khayat, Rina Walther, Avi Gabai
  • Publication number: 20140223605
    Abstract: This invention relates generally to a plant cell with enhanced nitrogen use efficiency and/or increased biomass production as compared to a corresponding non-transformed wild type plant cell by increasing or generating one or more activities of polypeptides associated with enhanced nitrogen use efficiency in plants.
    Type: Application
    Filed: January 9, 2014
    Publication date: August 7, 2014
    Applicant: BASF Plant Science GmbH
    Inventors: Piotr Puzio, Oliver Bläsing, Oliver Thimm, Gerhard Ritte, Hardy Schön
  • Publication number: 20140206035
    Abstract: Provided are isolated polypeptides having glucoamylase activity, catalytic domains, and polynucleotides encoding the polypeptides, catalytic domains. Also provided are nucleic acid constructs, vectors and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides, catalytic domains.
    Type: Application
    Filed: August 24, 2012
    Publication date: July 24, 2014
    Inventors: Tianqi Sun, Ming Li
  • Publication number: 20140208462
    Abstract: The present disclosure relates, in some embodiments, to compositions, organisms, systems, and methods for expressing a gene product in a plant using a expression control sequence (ECS) operable in monocots and/or dicots. For example, (i) an isolated nucleic acid may comprise an ECS (e.g., a sugarcane bacilliform virus promoter) and, optionally, an exogenous nucleic acid (ExNA) operably linked to the ECS; (ii) an expression vector may comprise an ECS; an ExNA; and, optionally, a 3? termination sequence, wherein the ECS has promoter activity sufficient to express the ExNA in at least one monocot and at least one dicot; (iii) a microorganism, plant cell, or plant may comprise an isolated nucleic acid; (iv) a method for constitutively expressing an ExNA in a plant (e.g.
    Type: Application
    Filed: February 20, 2014
    Publication date: July 24, 2014
    Applicant: THE TEXAS A&M UNIVERSITY SYSTEM
    Inventors: Mona DAMAJ, T. Erik MIRKOV
  • Publication number: 20140196174
    Abstract: The present invention relates to transgenic potato plants having an increased resistance against Phytophthora infestans and a comparable yield of potato tubers compared with the wildtype potato plants, wherein the blb1-gen and blb2-gen are integrated within a specific genetic background into the potato plant.
    Type: Application
    Filed: May 24, 2012
    Publication date: July 10, 2014
    Applicant: BASF PLANT SCIENCE COMPANY GMBH
    Inventors: Holger Schultheiss, Timo Böhme
  • Publication number: 20140178561
    Abstract: Materials and methods are provided for making plants (e.g., Solanum varieties) with decreased accumulation of reducing sugars and acrylamide in cold-stored potatoes, specifically, by making TALE-nuclease-induced mutations in genes encoding vacuolar invertase.
    Type: Application
    Filed: December 20, 2013
    Publication date: June 26, 2014
    Applicant: Cellectis
    Inventors: Luc Mathis, Daniel F. Voytas, Feng Zhang, Benjamin Clasen, William Haun, Thomas Stoddard
  • Publication number: 20140173776
    Abstract: The present invention refers to method for producing a transgenic plant with increased herbicide tolerance or resistance as compared to a corresponding non-transformed wild type plant, comprising transforming a plant cell or a plant cell nucleus or a plant tissue with a nucleic acid molecule encoding an Alopecurus cytochrome P450 monooxygenase, as well as to the nucleic acid, and plants with increased herbicide tolerance or resistance comprising the nucleic acid of the invention.
    Type: Application
    Filed: August 29, 2013
    Publication date: June 19, 2014
    Applicant: BASF SE
    Inventors: Stefan TRESCH, Doreen SCHACHTSCHABEL, Maciej PASTERNAK, Liliana PARRA RAPADO, Jens LERCHL, Thomas MIETZNER, Martin LaFOREST
  • Publication number: 20140147436
    Abstract: The present invention concerns polypeptides comprising a variant Fc region. More particularly, the present invention concerns Fc region-containing polypeptides that have altered effector function as a consequence of one or more amino acid modifications in the Fc region thereof.
    Type: Application
    Filed: July 19, 2013
    Publication date: May 29, 2014
    Applicant: GENENTECH, INC.
    Inventor: Leonard G. PRESTA
  • Patent number: 8710207
    Abstract: The present disclosure relates, in some embodiments, to compositions, organisms, systems, and methods for expressing a gene product in a plant using a expression control sequence (ECS) operable in monocots and/or dicots. For example, (i) an isolated nucleic acid may comprise an ECS (e.g., a sugarcane bacilliform virus promoter) and, optionally, an exogenous nucleic acid (ExNA) operably linked to the ECS; (ii) an expression vector may comprise an ECS; an ExNA; and, optionally, a 3? termination sequence, wherein the ECS has promoter activity sufficient to express the ExNA in at least one monocot and at least one dicot; (iii) a microorganism, plant cell, or plant may comprise an isolated nucleic acid; (iv) a method for constitutively expressing an ExNA in a plant (e.g.
    Type: Grant
    Filed: May 10, 2011
    Date of Patent: April 29, 2014
    Assignee: The Texas A&M University Systems
    Inventors: T. Erik Mirkov, Jong Won Park, San-Ji Gao
  • Publication number: 20140115736
    Abstract: The present invention relates to diploid, fertile, self-compatible and essentially homozygous potato lines, wherein said lines comprise an agronomically desirable trait such as vigour. The invention further relates to methods for producing such plants and to hybrid seeds obtained by crossing such homozygous potato lines and to potato plants grown from said seed.
    Type: Application
    Filed: April 20, 2012
    Publication date: April 24, 2014
    Inventors: Willem Hendrik Lindhout, Teunis Philippus Schotte, Richard Gerardus Franciscus Visser, Herman Johannes Van Eck, Ronaldus Cornelis Bernardus Hutten
  • Publication number: 20140090111
    Abstract: The invention provides fusion proteins comprising at least two fluorescent proteins, with the fluorescent proteins emitting different wavelengths of light from one another, at least one plant hormone binding domain that changes three-dimensional conformation upon specifically binding to a plant hormone, and two linker peptides, with the first linker linking the first fluorescent protein to the N-terminus of the plant hormone binding domain and the second linker linking the second fluorescent protein to the C-terminus of the plant hormone binding domain. The invention also provides for methods of using the fusion proteins of the present invention and nucleic acids encoding the fusion proteins.
    Type: Application
    Filed: September 5, 2013
    Publication date: March 27, 2014
    Applicant: Carnegie Institution of Washington
    Inventors: Wolf B. Frommer, Alexander M. Jones
  • Publication number: 20140082763
    Abstract: A potato cultivar designated ‘FL 2322’ is disclosed. The invention relates to tubers and seeds of potato cultivar ‘FL 2322’, to plants of potato cultivar ‘FL 2322’, to plant parts of potato cultivar ‘FL 2322’ and to methods for producing progeny of potato cultivar ‘FL 2322’. The invention relates to methods for producing a potato plant containing in its genome one or more transgenes and to the transgenic potato plants and plant parts produced by those methods. This invention relates to potato cultivars or breeding cultivars and plant parts derived from potato variety ‘FL 2322’, to methods for producing other potato cultivars, lines or plant parts derived from potato cultivar ‘FL 2322’ and to potato plants, varieties, and their parts derived from use of those methods. The invention further relates to hybrid potato tubers, seeds, plants and plant parts produced by crossing potato cultivar ‘FL 2322’ with another potato cultivar.
    Type: Application
    Filed: September 14, 2012
    Publication date: March 20, 2014
    Applicant: FRITO-LAY NORTH AMERICA, INC.
    Inventor: Robert W. Hoopes
  • Publication number: 20140082762
    Abstract: A potato cultivar designated ‘FL 2312’ is disclosed. The invention relates to tubers and seeds of potato cultivar ‘FL 2312’, to plants of potato cultivar ‘FL 2312’, to plant parts of potato cultivar ‘FL 2312’ and to methods for producing progeny of potato cultivar ‘FL 2312’. The invention relates to methods for producing a potato plant containing in its genome one or more transgenes and to the transgenic potato plants and plant parts produced by those methods. This invention relates to potato cultivars or breeding cultivars and plant parts derived from potato variety ‘FL 2312’, to methods for producing other potato cultivars, lines or plant parts derived from potato cultivar ‘FL 2312’ and to potato plants, varieties, and their parts derived from use of those methods. The invention further relates to hybrid potato tubers, seeds, plants and plant parts produced by crossing potato cultivar ‘FL 2312’ with another potato cultivar.
    Type: Application
    Filed: September 14, 2012
    Publication date: March 20, 2014
    Applicant: FRITO-LAY NORTH AMERICA, INC.
    Inventor: Robert W. Hoopes
  • Publication number: 20140075600
    Abstract: The present invention relates to a valencene synthase, to a nucleic acid encoding such valencene synthase, to a host cell comprising said encoding nucleic acid sequence and to a method for preparing valencene, comprising converting farnesyl diphosphate to valencene in the presence of a valencene synthase according to the invention.
    Type: Application
    Filed: December 15, 2010
    Publication date: March 13, 2014
    Applicant: Isobionics B.V.
    Inventors: Jihane Achkar, Theodorus Sonke, Martinus Julius Beekwilder, Hendrik Jan Bouwmeester, Hendrik Jan Bosch
  • Publication number: 20140068812
    Abstract: The present invention discloses regulatory sequences, promoters and terminators, and their use in plants. The regulatory sequences can be used to make gene constructs that include a gene not natively associated with the regulatory sequences. Methods to use the regulatory sequences with antisense constructs or functional RNAs are disclosed. Methods to use the regulatory sequences, promoter or terminator, independently of each other are also disclosed. Methods to use the regulatory sequences to improve plant growth and production such as increased biomass, increased yield and increased tolerance to abiotic or biotic stresses are also disclosed.
    Type: Application
    Filed: April 23, 2012
    Publication date: March 6, 2014
    Applicant: PLANT SENSORY SYSTEMS, LLC
    Inventors: Frank J. Turano, Kathleen A. Turano
  • Publication number: 20140053295
    Abstract: Compositions and methods for conferring hydroxyphenyl pyruvate dioxygenase (HPPD) herbicide resistance or tolerance to plants are provided. Compositions include amino acid sequences, and variants and fragments thereof, for mutant HPPD polypeptides. Nucleic acids that encode the mutant HPPD polypeptides are also provided. Methods for conferring herbicide resistance or tolerance, particularly resistance or tolerance to certain classes of herbicides that inhibit HPPD, in plants are further provided. Methods are also provided for selectively controlling weeds in a field at a crop locus and for the assay, characterization, identification and selection of the mutant HPPDs of the current invention that provide herbicide tolerance.
    Type: Application
    Filed: August 9, 2012
    Publication date: February 20, 2014
    Inventors: Timothy Robert Hawkes, Michael Phillip Langford, Russell Colin Viner, Bernardus Theodorus Maria Vernooij, Richard Dale
  • Publication number: 20140041072
    Abstract: The invention relates to a new resistance gene, Rpi-edn2 and functional homologues or functional fragments thereof isolated from S. x edinense. Moreover, the invention relates to the use of said resistance gene, for example the use of said resistance gene in a method to increase or confer at least partial resistance in a plant to an oomycete infection. The invention provides an isolated or recombinant nucleic acid sequence comprising a nucleic acid sequence encoding one of the amino acid sequences of FIG. 4 or a functional fragment or a functional homologue thereof.
    Type: Application
    Filed: May 31, 2011
    Publication date: February 6, 2014
    Applicant: COOPERATIE AVEBE U.A.
    Inventors: Nicolaas Clemens Maria Henricus de Vetten, Estelle Celine Verzaux, Jacobus Hubertus Vossen, Hendrik Rietman, Vivianne Gertruda Antonia Anna Vleeshouwers, Evert Jacobsen, Richard Gerardus Franciscus Visser
  • Publication number: 20130315918
    Abstract: Anti-VEGF antibodies and variants thereof, including those having high affinity for binding to VEGF, are disclosed. Also provided are methods of using phage display technology with naïve libraries to generate and select the anti-VEGF antibodies with desired binding and other biological activities. Further contemplated are uses of the antibodies in research, diagnostic and therapeutic applications.
    Type: Application
    Filed: June 27, 2013
    Publication date: November 28, 2013
    Applicant: Genentech, Inc.
    Inventors: GERMAINE FUH, HANS-PETER GERBER, WEI-CHING LIANG, FREDERIC FELLOUSE, SACHDEV S. SIDHU, CHRISTIAN WIESMANN